Slide stainer automate the staining of prepared cytology or histology tissue specimens by diffusing dyes into the specimens through surface adsorption, direct staining, indirect staining, or mordant staining. Rising demand from laboratories and research centers is a major factor expected to drive growth of the global market over the forecast period.

The global slide stainer market has been segmented on the basis of product, technology, end user, and region. On the basis of product, the target market is segmented into reagents, equipment, consumables and accessories.

On the basis of technology, the target market is segmented into hematoxylin and eosin, immunohistochemistry, in situ hybridization, cytology, microbiology, hematology, and special stains. The hematoxylin and eosin segment is expected to register highest growth in terms of revenue in the target market during the forecast period.

On the basis of end user, the global market is segmented into hospitals and diagnostic centers, academic and research institutes, and pharmaceutical and biotechnology companies. The hospitals and diagnostic centers segment is expected to witness highest growth in the target market during the forecast period.

Request for the Sample Report Here: https://marketresearch.biz/report/slide-stainer-market/request-sample/

On the basis of region, the global slide stainer market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts for highest share in terms of revenue and is expected to dominate the global market during the forecast period, due to rising demand for product from various end users coupled with presence of major manufacturers in this region. The market in Europe is expected to account for significant share in terms of revenue, followed by the Asia Pacific market. The Asia Pacific market is projected to witness highest growth in terms of revenue over the forecast period.

Key players operating in the global slide stainer market include F. Hoffmann-La Roche Ltd, Danaher Corporation, BioGenex Laboratories, Inc., Thermo Fisher Scientific, Merck KGaA, Biocare Medical, LLC., Sakura Finetek Europe B.V., Hardy Diagnostics, General Data Company Inc., and ELITechGroup.